IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

SV Life Sciences Advisers, LLC

Q2 2016 Holdings

Filed 2016-08-12 | 6 holdings | $99.0K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Entellus MED IncCOM29363K105$63.8K3,489,53364.4%
Catabasis Pharmaceuticals inCOM14875P107$10.6K2,857,66710.7%
Ocular Therapeutix Inc(OCUL)COM67576A100$9.6K1,932,6079.7%
Transenterix IncCOM NEW89366M201$9.2K7,546,6929.3%
Raptor Pharmaceutical CorpCOM75382F106$4.8K888,1324.8%
Lombard MED IncCOMG55598109$1.2K1,077,4991.2%